EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Prediction of Myasthenia Gravis Worsening: A Machine Learning Algorithm Using Wearables and Patient‐Reported Measures

Maike Stein iD, Haoqi Sun, Sophie Lehnerer iD, Lea Gerischer iD, Maximilian Mönch, Christian Meisel iD, Andreas Meisel, Pushpa Narayanaswami

Annals of Clinical and Translational Neurology · 2026-04 · 13 (4) · 714-723

DOI: 10.1002/acn3.70257 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 19.11.2025. Verfasst von Maike Stein und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology With Experimental Neurology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-…. Hauptthemen laut MEDLINE: Myasthenia Gravis, Patient Reported Outcome Measures, Machine Learning, Wearable Electronic Devices. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hormosan, UCB Pharma Germany, Argenx.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Myasthenia gravis (MG) is a rare disorder characterized by fluctuating muscle weakness with potential life‐threatening crises. Timely interventions may be delayed by limited access to care and fragmented documentation. Our objective was to develop predictive algorithms for MG deterioration using multimodal telemedicine data.

Methods

In this 12‐week randomized controlled study, 30 MG patients recorded symptoms using patient‐reported outcome measures (PROMs) and patient‐performed measures via a mobile app, alongside data from wearables. MG deterioration was defined as a ≥ 3‐point worsening in the Quantitative Myasthenia Gravis score, occurrence of MG‐related hospitalization or exacerbation. A machine learning linear classifier was trained to predict deterioration and cross‐validated. The area under the receiver operator characteristic curve (AUROC) was calculated, accepting 1–2 false alarms (FAs) per week.

Results

The model achieved the best predictive performance when using all input signals (AUROC 0.85 (95% confidence interval 0.77–0.91)) and remained stable across look‐back windows of 4–10 days. Model sensitivity was 0.65 (0.48–0.83) to 0.82 (0.60–1.00) (1 and 2 FAs per week, respectively). PROMs reflected worsening symptoms before deterioration; wearables alone showed higher AUROCs.

Interpretation

Multimodal self‐monitoring via MyaLink predicted MG deterioration with good performance at acceptable FA rates. This approach may enable earlier clinical interventions of MG worsening. Trial Registration The study was registered under the German Clinical Trial Registry (DRKS00029907)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myasthenia GravisPatient Reported Outcome MeasuresMachine LearningWearable Electronic DevicesDisease ProgressionHumansFemaleMaleMiddle AgedAgedAdultAlgorithmsTelemedicine

Stichwörter der Autor:innen

artificial intelligencemonitoringmyasthenia gravisremote consultationsensors

Autor:innen und Institutionen

  • Department of Neurology With Experimental Neurology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Neuroscience Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Department of Neurology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, Massachusetts, USA.
  • Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Center for Stroke Research Berlin, Charité - Universitätsmedizin Berlin, Berlin, Germany.

ORCID-Profile: Maike Stein, Sophie Lehnerer, Lea Gerischer, Christian Meisel

Förderung

  • Hormosan
  • UCB Pharma Germany
  • Argenx
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Stein, M., Sun, H., Lehnerer, S., Gerischer, L., Mönch, M., Meisel, C., Meisel, A., & Narayanaswami, P. (2026). Prediction of Myasthenia Gravis Worsening: A Machine Learning Algorithm Using Wearables and Patient‐Reported Measures. Annals of Clinical and Translational Neurology, 13(4), 714-723. https://doi.org/10.1002/acn3.70257

Vancouver

Stein M, Sun H, Lehnerer S, Gerischer L, Mönch M, Meisel C, et al. Prediction of Myasthenia Gravis Worsening: A Machine Learning Algorithm Using Wearables and Patient‐Reported Measures. Annals of Clinical and Translational Neurology. 2026;13(4):714-723. doi:10.1002/acn3.70257

BibTeX
@article{Stein2026,
  author = {Stein, Maike and Sun, Haoqi and Lehnerer, Sophie and Gerischer, Lea and Mönch, Maximilian and Meisel, Christian and Meisel, Andreas and Narayanaswami, Pushpa},
  title = {Prediction of Myasthenia Gravis Worsening: A Machine Learning Algorithm Using Wearables and Patient‐Reported Measures},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2026},
  volume = {13},
  number = {4},
  pages = {714--723},
  doi = {10.1002/acn3.70257}
}
Kostenlos starten →